Related Experiment Video
Updated: Mar 30, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Oncogenic Signaling Adaptor Proteins
1Health Sciences and Technology Program, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Signal transduction pathways activated by receptor tyrosine kinases (RTK) play a critical role in many aspects of cell function. Adaptor proteins serve an important scaffolding function that facilitates key signaling transduction events downstream of RTKs. Recent work integrating both structural and functional genomic approaches has identified several adaptor proteins as new oncogenes. In this review, we focus on the discovery, structure and function, and therapeutic implication of three of these adaptor oncogenes, CRKL, GAB2, and FRS2. Each of the three genes is recurrently amplified in lung adenocarcinoma or ovarian cancer, and is essential to cancer cell lines that harbor such amplification. Overexpression of each gene is able to transform immortalized human cell lines in in vitro or in vivo models. These observations identify adaptor protein as a distinct class of oncogenes and potential therapeutic targets.
Insights
Adaptor proteins CRKL, GAB2, and FRS2 are newly identified oncogenes. Amplification of these genes drives lung and ovarian cancers, highlighting them as potential therapeutic targets.
Area of Science:
- Molecular biology
- Cancer genetics
- Signal transduction
Background:
- Receptor tyrosine kinases (RTKs) activate critical cell signaling pathways.
- Adaptor proteins scaffold key signaling events downstream of RTKs.
- Recent genomic studies reveal adaptor proteins as novel oncogenes.
Purpose of the Study:
- To review the discovery, structure, function, and therapeutic potential of three adaptor oncogenes: CRKL, GAB2, and FRS2.
- To highlight the role of these adaptor proteins in cancer development.
Main Methods:
- Integration of structural and functional genomic approaches.
- Analysis of gene amplification in cancer cell lines.
- In vitro and in vivo transformation assays.
Main Results:
- CRKL, GAB2, and FRS2 are recurrently amplified in lung adenocarcinoma and ovarian cancer.
- These amplified genes are essential for cancer cell line survival.
- Overexpression transforms immortalized human cell lines.
Conclusions:
- Adaptor proteins represent a distinct class of oncogenes.
- These adaptor oncogenes are crucial drivers of specific cancers.
- CRKL, GAB2, and FRS2 are promising therapeutic targets for cancer treatment.
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Intracellular Signaling Affects Focal Adhesions
Some...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression

